The U.S. Food and Drug Administration has approved GSK's add-on drug to treat asthma and a chronic inflammatory sinus condition, the drugmaker said on Tuesday, paving the way for a less frequently ...

Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...

Royalty Pharma is acquiring a low-single digit pre-existing royalty on worldwide net sales on each of Nuvalent’s neladalkib and zidesamtinib from an undisclosed third party for up to $315 million. The ...

A user on X shared that his relative found an old share certificate of Burroughs Wellcome India Ltd, purchased in 1993.

Work to turn a Victorian auction mart into a community space for a town is to begin in the new year. The disused mart on ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the purchase of 230,000 of its own ordinary shares as part of its ongoing ...

GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...

The Non-Opioid Therapeutics Market is rapidly expanding due to increased demand for safer pain management Non-Opioid Therapeutics Market Non-Opioid Therapeutics Market Dublin, Dec. 11, 2025 (GLOBE ...

Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult ...

In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the ...